Scott Isaacs, president-elect of the American Association of Clinical Endocrinology, describes patients who lost significant weight on semaglutide while taking other medications that required dose adjustments they didn't know about
Adems, Argentina es uno de los 20 pases en el mundo que, segn las proyecciones de Unicef, en el ao 2030 podra superar los 2 millones de nios, nias y adolescentes con elevados ndices de masa corporal.
Gartlehner G, Patel SV, Reddy S, Rains C, Schwimmer M, Kahwati L
(Updated from ClinicalTrials.gov on 10 June 2025)
Results Efficacy-to-tolerability ratio is lower for women on GLP1R agonists Approximately 70% of people taking a GLP1R agonist for weight loss are female (Fig
This special interplay further highlights that the loss of any one system can overwhelm the compensatory capacity of the others, forcing the CNS into a state of redox imbalance, glial activation, and progressive inflammation (Figure 1)